期刊文献+

糖尿病肾病病人醛糖还原酶基因多态性相关研究

STUDY ON THE GENE POLYMORPHISIMS OF ALDOSE REDUCTASE IN TYPE 2 DIABETIC NEPHROPATHY
暂未订购
导出
摘要 目的探讨醛糖还原酶(AR)基因5′端(AC)n多态性与2型糖尿病肾病的关系。方法采用聚合酶链反应(PCR)、聚丙烯酰胺凝胶电泳及银染色技术分析了139例2型糖尿病病人(早期糖尿病肾病组61例,非糖尿病肾病组78例)和63例正常对照者AR基因5′端(AC)n的多态性。结果早期糖尿病肾病组Z-2等位基因频率高于非糖尿病肾病组和正常对照组(χ2=6.88、10.51,P<0.01);含Z-2等位基因的基因型频率也高于非糖尿病肾病组和正常对照组(χ2=4.95、8.15,P<0.05、0.01)。结论AR基因Z-2等位基因与青岛地区汉族2型糖尿病病人糖尿病肾病的发生发展有关。 Objective To investigate the association between (AC)n polymorphisms at 5-end of the aldose reductase gene and diabetic nephropathy of Type 2 diabetes mellitus. Methods The 5'-ALR polymorphism in 139 patients with Type 2 diabetes (61 cases with nephropathy, 78 without nephropathy) and 63 healthy controls was identified in genomic DNA using polymerase chain reaction and PAGE gel electrophoresis together with silver-staining. Results The frequency of allele Z-2 was significantly higher in patients with diabetic nephropathy compared with that of without nephrophaty and controls (x^2= 6. 88,10. 51;P〈 0.01). The genotypic frequency of allele Z- 2 was significantly higher in those with diabetic nephropathy compared with that of without nephrophaty and controls (x^2=4.95,8.15;P〈0.05,0.01). Conclusion Allele Z-2 of aldose reductase may contribute to the pathogenesis of diabetic nephropathy with type 2 diabetes mellitus.
出处 《青岛大学医学院学报》 CAS 2007年第4期308-310,共3页 Acta Academiae Medicinae Qingdao Universitatis
基金 山东省科技厅博士基金资助项目(02BS094)
关键词 糖尿病肾病 醛还原酶 基因型 基因频率 diabetic nephropathies aldose reductase geneotype gene frequency DN, DN
  • 相关文献

参考文献9

  • 1YAMAMOTO T,SATO T,HOSOI M,et al.Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus[J].Diabetes Obes Metab,2003,5(1):51-57.
  • 2WAT N M,LIU Y F.Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with type 2 diabetes[J].Diabetes Med,2002,19(2):113-118.
  • 3李长贵,吕淑云,綦玉琴,王娈,闫胜利.eNOS基因第7外显子894G→T点突变与早期糖尿病肾病并高血压的关系[J].青岛大学医学院学报,2004,40(3):200-202. 被引量:7
  • 4邢广群,孙建平,刘丽秋,袁鹰,于宁,赵震霄.糖尿病肾病病人血清胰岛素样生长因子的测定[J].青岛大学医学院学报,2002,38(1):34-36. 被引量:4
  • 5KO B C,LAM K S,WAT N M,et al.An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients[J].Diabetes,1995,44(7):727-732.
  • 6KUMARAMANICKAVEL G,SRIPRIYA S,RAMPRASED V L,et al.Z-2 aldose reductase allele and diabetic retinopathy in India[J].Ophthalmic Genet,2003,24(1):41-48.
  • 7PETROVIC M G,PETERLIN B,HAWLINA M,et al.Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians[J].Diabetes Complications,2005,19(2):70-73.
  • 8YANG B,MILLWARD A,DEMAINE A.Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications[J].Biochim Biophys Acta,2003,1639(1):1-7.
  • 9LIU Y F,WAT N M,CHUNG S S,et al.Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes[J].Diabet Med,2002,19(2):113-118.

二级参考文献17

  • 1[1]Forte P, Copland M, Smith L, et al. Basal nitric oxide synthesis in essential hypertension[J]. Lancet,1997,349:837.
  • 2[3]Wang XL,Mahaney MC,Sim AS,et al.Genetic contribution of the endothelial constitutive nitric oxide snythase gene to plasma nitric oxide levels[J]. Arterioscler Thromb Vasc Biol,1997,17(11):3147.
  • 3[4]Miyamoto Y,Satito Y,Kajiyama N,et al. Endothelial nitric oxide snythase gene is positively associated with essential hypertention[J]. Hypertention,1998,32:3.
  • 4[5]Yasujima M,Tsutaya S,Shoji M,et al. Endothelial nitric oxide snythase gene polymorphysim and hypertention[J].Rinsho Byori,1998,46:1199.
  • 5[6]Jachymova M,Horky K,Bultas J,et al.Association of the Glu298Asp polymorphysim in the endothelial nitric oxide snythase gene with essential hypertention resistant to conventional therapy[J].Biochem Biophys Res Commum,2001,284(2):426.
  • 6[7]Benjafield AV,Morris BJ.Association analyses of nitric oxide snythase gene polymorphyism in essential hypertention[J].Am J Hypertens,2002,13(9):994.
  • 7[8]Tsujita Y,Babas S,Yamauchi R,et al. Association analyses between genetic polymorphyism of endothelial nitric oxide snythase gene and hypertention in Jpaneses:the Suita study[J].J Hypertense, 2001,19:1941.
  • 8Flyvbjerg A,Landau D,Domene H, et al.The role of growth hormone,insulin-like growth factors and IGF-binding proteins in experimental diabetic kidney disease[J]. Metabolism,1995, 44(10 Suppl 4 ):67
  • 9Flyvbjerg A,Frystyk J,фsterby R, et al.Kidney IGF-1 and renal hypertrophy in GH deficient dwarf rats[J]. Am J Physiol,1992, 262[J]:E956
  • 10Schreiber BD,Hughes ML,Groggel GC.Insulin-like growth factor-1 stimulates production of mesangial cell matrix components[J]. Clin Nephrol, 1995, 43(6):368

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部